Literature DB >> 29273446

Stress hyperglycemia in general surgery: Why should we care?

Georgia Davis1, Maya Fayfman1, David Reyes-Umpierrez1, Shahzeena Hafeez1, Francisco J Pasquel1, Priyathama Vellanki1, J Sonya Haw1, Limin Peng2, Sol Jacobs1, Guillermo E Umpierrez3.   

Abstract

AIMS: To determine the frequency of increasing levels of stress hyperglycemia and its associated complications in surgery patients without a history of diabetes.
METHODS: We reviewed hospital outcomes in 1971 general surgery patients with documented preoperative normoglycemia [blood glucose (BG) <140mg/dL] who developed stress hyperglycemia (BG >140mg/dL or >180mg/dL) within 48h after surgery between 1/1/2010 and 10/31/2015.
RESULTS: A total of 415 patients (21%) had ≥1 episode of BG between 140 and 180mg/dL and 206 patients (10.5%) had BG>180mg/dL. The median length of hospital stay (LOS) was 9days [interquartile range (IQR) 5,15] for BG between 140 and 180mg/dL and 12days (IQR 6,18) for BG>180mg/dL compared to normoglycemia at 6days (IQR 4,11), both p<0.001. Patients with BG 140-180mg/dL had higher rates of complications with an odds ratio (OR) of 1.68 [95% confidence interval (95% CI) 1.15-2.44], and those with BG>180mg/dL had more complications [OR 3.46 (95% CI 2.24-5.36)] and higher mortality [OR 6.56 (95% CI 2.12-20.27)] compared to normoglycemia.
CONCLUSION: Increasing levels of stress hyperglycemia are associated with higher rates of perioperative complications and hospital mortality in surgical patients without diabetes.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  General surgery; Hospital complications; Hospital hyperglycemia; Hospital mortality; Inpatient hyperglycemia; Stress hyperglycemia

Mesh:

Substances:

Year:  2017        PMID: 29273446      PMCID: PMC5975368          DOI: 10.1016/j.jdiacomp.2017.11.010

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  27 in total

Review 1.  Management of diabetes and hyperglycemia in hospitals.

Authors:  Stephen Clement; Susan S Braithwaite; Michelle F Magee; Andrew Ahmann; Elizabeth P Smith; Rebecca G Schafer; Irl B Hirsch; Irl B Hirsh
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

2.  Impact of hyperglycemia on perioperative mortality after coronary artery bypass graft surgery.

Authors:  Andrea Székely; Jack Levin; Yinghui Miao; Iulia C Tudor; Alain Vuylsteke; Peter Ofner; Dennis T Mangano
Journal:  J Thorac Cardiovasc Surg       Date:  2011-04-17       Impact factor: 5.209

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes.

Authors:  Meera Kotagal; Rebecca G Symons; Irl B Hirsch; Guillermo E Umpierrez; E Patchen Dellinger; Ellen T Farrokhi; David R Flum
Journal:  Ann Surg       Date:  2015-01       Impact factor: 12.969

Review 5.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.

Authors:  Joseph L Evans; Ira D Goldfine; Betty A Maddux; Gerold M Grodsky
Journal:  Endocr Rev       Date:  2002-10       Impact factor: 19.871

6.  Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.

Authors:  James Stephen Krinsley
Journal:  Mayo Clin Proc       Date:  2003-12       Impact factor: 7.616

7.  Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises.

Authors:  Frankie B Stentz; Guillermo E Umpierrez; Ruben Cuervo; Abbas E Kitabchi
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

8.  Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery.

Authors:  R Ascione; C A Rogers; C Rajakaruna; G D Angelini
Journal:  Circulation       Date:  2008-07-08       Impact factor: 29.690

9.  Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus.

Authors:  Paolo Gresele; Giuseppe Guglielmini; Massimiliano De Angelis; Silvia Ciferri; Marco Ciofetta; Emanuela Falcinelli; Carlo Lalli; Giovanni Ciabattoni; Giovanni Davì; Geremia B Bolli
Journal:  J Am Coll Cardiol       Date:  2003-03-19       Impact factor: 24.094

10.  Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial.

Authors:  Guillermo Umpierrez; Saumeth Cardona; Francisco Pasquel; Sol Jacobs; Limin Peng; Michael Unigwe; Christopher A Newton; Dawn Smiley-Byrd; Priyathama Vellanki; Michael Halkos; John D Puskas; Robert A Guyton; Vinod H Thourani
Journal:  Diabetes Care       Date:  2015-07-15       Impact factor: 19.112

View more
  8 in total

Review 1.  Use of Insulin in the Inpatient Setting: Need for Continued Use.

Authors:  Smita Kumar; Mark E Molitch
Journal:  Curr Diab Rep       Date:  2019-07-26       Impact factor: 4.810

2.  Practice of hyperglycaemia control in intensive care units of the Military Hospital, Sudan-Needs of a protocol.

Authors:  Ghada Omer Hamad Abd El-Raheem; Mudawi Mohammed Ahmed Abdallah; Mounkaila Noma
Journal:  PLoS One       Date:  2022-05-24       Impact factor: 3.752

3.  Effect of Intraoperative Magnesium Sulfate Administration on Blood Glucose Control following Total Joint Arthroplasty in Patients with Diabetes.

Authors:  Jin-Woo Park; Eun-Kyoung Kim; Jiyoun Lee; Seung Hyun Chung; Gihong Boo; Sang-Hwan Do
Journal:  J Clin Med       Date:  2022-05-27       Impact factor: 4.964

4.  Exploring a Novel Screening Method for Patients with Oral Squamous Cell Carcinoma: A plasma Metabolomics Analysis.

Authors:  Yui Enomoto; Akira Kimoto; Hiroaki Suzuki; Shin Nishiumi; Masaru Yoshida; Takahide Komori
Journal:  Kobe J Med Sci       Date:  2018-09-11

5.  Hyperglycemia minimally alters primary self-renewing human colonic epithelial cells while TNFα-promotes severe intestinal epithelial dysfunction.

Authors:  Johanna S Dutton; Samuel S Hinman; Raehyun Kim; Peter J Attayek; Mallory Maurer; Christopher S Sims; Nancy L Allbritton
Journal:  Integr Biol (Camb)       Date:  2021-06-15       Impact factor: 2.192

6.  Using a Diabetes Risk Score to Identify Patients Without Diabetes at Risk for New Hyperglycemia in the Hospital.

Authors:  Carlos E Mendez; Rebekah J Walker; Aprill Z Dawson; Kevin Lu; Leonard E Egede
Journal:  Endocr Pract       Date:  2021-04-19       Impact factor: 3.701

7.  Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: A pilot randomized study.

Authors:  Maya Fayfman; Georgia Davis; Elizabeth W Duggan; Maria Urrutia; David Chachkhiani; Joanna Schindler; Francisco J Pasquel; Rodolfo J Galindo; Priyathama Vellanki; David Reyes-Umpierrez; Heqiong Wang; Guillermo E Umpierrez
Journal:  J Diabetes Complications       Date:  2018-09-01       Impact factor: 2.852

8.  Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery.

Authors:  Saumeth Cardona; Katerina Tsegka; Francisco J Pasquel; Maya Fayfman; Limin Peng; Sol Jacobs; Priyathama Vellanki; Michael Halkos; Robert A Guyton; Vinod H Thourani; Rodolfo J Galindo; Guillermo Umpierrez
Journal:  BMJ Open Diabetes Res Care       Date:  2019-09-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.